PRASFIT-ACS: Important Evidence Against a "One-Guideline-Fits-All-Races" Approach to Antiplatelet Therapy
スポンサーリンク
概要
著者
-
Ahn Jong-hwa
Division Of Hematology And Oncology Department Of Internal Medicine School Of Medicine Gyeongsang Na
-
TANTRY Udaya
Sinai Center for Thrombosis Research
-
GURBEL Paul
Sinai Center for Thrombosis Research
-
Jeong Young-Hoon
Division of Cardiology, Gyeongsang National University Hospital and Gyeongsang National University School of Medicine
-
Kim Kye-Hwan
Division of Cardiology, Gyeongsang National University Hospital and Gyeongsang National University School of Medicine
-
Ahn Jong-Hwa
Division of Cardiology, Gyeongsang National University Hospital and Gyeongsang National University School of Medicine
関連論文
- Coexistence of chronic myeloid leukemia and pulmonary plasmacytoma mimicking primary lung cancer
- Cilostazol to Overcome High On-Treatment Platelet Reactivity in Korean Patients Treated With Clopidogrel and Calcium-Channel Blocker
- Isolated Mediastinal Myeloid Sarcoma Successfully Treated with Chemoradiotherapy Followed by Unrelated Allogeneic Stem Cell Transplantation
- PRASFIT-ACS: Important Evidence Against a "One-Guideline-Fits-All-Races" Approach to Antiplatelet Therapy